10x Genomics (TXG)公布第三季度亏损,但营收超预期 - 纳斯达克
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
生物技术与制药领域的最新动态
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics Reports Third Quarter 2025 Financial Results - PR Newswire
Solving formulation challenges with Lonza’s advanced technologies - Nutraceutical Business Review
Cytiva Launches Fibro dT Platform - Contract Pharma
China to lift 8-month ban on imports of Illumina’s gene sequencers - Times of San Diego
Illumina shares rise as China set to lift sequencer export ban - Fierce Biotech
Illumina’s Constellation and 5-Base Unlock New Depths of DNA Insights - Technology Networks
Illumina says China is lifting export ban - MedTech Dive
Thermo Fisher Scientific declares $0.43 quarterly dividend - Investing.com
Thermo Fisher Scientific Declares Quarterly Dividend payable on January 15, 2026 - BioSpace
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - BioSpace
10x Genomics scales single-cell analysis platform amid growing market demand - R&D World
Waters Corporation (NYSE:WAT) Q3 2025 Earnings Call Transcript - Insider Monkey
Lonza head of bioscience talks recent Redberry acquisition - BioProcess International